A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19

Clinical trial NCT04640194 · COMPLETED

Trial details

NCT number: NCT04640194
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome

Start date: 2020-12-16
Primary completion: 2022-07-19
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.